Ensem Therapeutics

ENSEM Therapeutics (“ENSEM”) is a Boston-based preclinical-stage biopharmaceutical company targeting high-value and “undruggable” targets. It develops innovative small-molecule drugs based on protein/RNA kinetic ensemble-based drug discovery. The company’s mission is to discover, develop, and commercialize transformative oncology therapies for patients while leading advancements in AI-driven structural integration and computational drug design. Currently focused primarily on oncology treatments, the company plans to expand into genetic disorders and other disease areas in the future.